
<!DOCTYPE html>
<html lang="en-US" prefix="og: http://ogp.me/ns#">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width initial-scale=1.0"/>
<title>VASCEPA (icosapent ethyl)—VASCEPA efficacy in other atherogenic biomarkers</title>

<!-- This site is optimized with the Yoast SEO plugin v2.3.4 - https://yoast.com/wordpress/plugins/seo/ -->
<meta name="description" content="VASCEPA significantly reduced levels of other atherogenic biomarkers."/>
<meta name="keywords" content="VASCEPA, VLDL-C, non–HDL-C, Apo B, LDL particle number, MARINE trial, APOCIII, APOC3"/>
<link rel="canonical" href="http://vascepahcp.com/vascepa-other-biomarkers"/>
<meta property="og:locale" content="en_US"/>
<meta property="og:type" content="article"/>
<meta property="og:title" content="VASCEPA (icosapent ethyl)—VASCEPA efficacy in other atherogenic biomarkers"/>
<meta property="og:description" content="VASCEPA significantly reduced levels of other atherogenic biomarkers."/>
<meta property="og:url" content="http://vascepahcp.com/vascepa-other-biomarkers"/>
<meta property="og:site_name" content="Vascepa"/>
<meta property="og:image" content="http://www.vascepahcp.com/wp-content/uploads/2015/03/VLDL-C-Non-HDL-C-Apo-B-Chart.png"/>
<meta property="og:image" content="http://www.vascepahcp.com/wp-content/uploads/2015/03/VLDL-C-Non-HDL-C-Apo-B-Chart-thumb.png"/>
<!-- / Yoast SEO plugin. -->

<link rel="alternate" type="application/rss+xml" title="Vascepa &raquo; Other atherogenic biomarkers Comments Feed" href="http://vascepahcp.com/vascepa-other-biomarkers/feed/"/>
<script type="text/javascript">window._wpemojiSettings={"baseUrl":"http:\/\/s.w.org\/images\/core\/emoji\/72x72\/","ext":".png","source":{"concatemoji":"http:\/\/vascepahcp.com\/wp-includes\/js\/wp-emoji-release.min.js?ver=4.2.4"}};!function(a,b,c){function d(a){var c=b.createElement("canvas"),d=c.getContext&&c.getContext("2d");return d&&d.fillText?(d.textBaseline="top",d.font="600 32px Arial","flag"===a?(d.fillText(String.fromCharCode(55356,56812,55356,56807),0,0),c.toDataURL().length>3e3):(d.fillText(String.fromCharCode(55357,56835),0,0),0!==d.getImageData(16,16,1,1).data[0])):!1}function e(a){var c=b.createElement("script");c.src=a,c.type="text/javascript",b.getElementsByTagName("head")[0].appendChild(c)}var f,g;c.supports={simple:d("simple"),flag:d("flag")},c.DOMReady=!1,c.readyCallback=function(){c.DOMReady=!0},c.supports.simple&&c.supports.flag||(g=function(){c.readyCallback()},b.addEventListener?(b.addEventListener("DOMContentLoaded",g,!1),a.addEventListener("load",g,!1)):(a.attachEvent("onload",g),b.attachEvent("onreadystatechange",function(){"complete"===b.readyState&&c.readyCallback()})),f=c.source||{},f.concatemoji?e(f.concatemoji):f.wpemoji&&f.twemoji&&(e(f.twemoji),e(f.wpemoji)))}(window,document,window._wpemojiSettings);</script>
<style type="text/css">img.wp-smiley,img.emoji{display:inline!important;border:none!important;box-shadow:none!important;height:1em!important;width:1em!important;margin:0 .07em!important;vertical-align:-.1em!important;background:none!important;padding:0!important}</style>
<link rel='stylesheet' id='contact-form-7-css' href='http://vascepahcp.com/wp-content/plugins/contact-form-7/includes/css/A.styles.css,qver=4.2.2.pagespeed.cf.Io6Fs5icoS.css' type='text/css' media='all'/>
<link rel='stylesheet' id='mainstyle-css' href='http://vascepahcp.com/wp-content/themes/Vascepa/style.css?ver=4.2.4' type='text/css' media='all'/>
<script type='text/javascript' src='//ajax.googleapis.com/ajax/libs/jquery/1.11.0/jquery.min.js?ver=4.2.4'></script>
<script type='text/javascript' src='http://vascepahcp.com/wp-content/themes/Vascepa/includes/main.js?ver=4.2.4'></script>
<link rel="EditURI" type="application/rsd+xml" title="RSD" href="http://vascepahcp.com/xmlrpc.php?rsd"/>
<link rel="wlwmanifest" type="application/wlwmanifest+xml" href="http://vascepahcp.com/wp-includes/wlwmanifest.xml"/> 
<meta name="generator" content="WordPress 4.2.4"/>
<link rel='shortlink' href='http://vascepahcp.com/?p=23'/>
<script type="text/javascript">if(navigator.userAgent.match(/iPad/i)){viewport=document.querySelector("meta[name=viewport]");viewport.setAttribute('content','width=960');}</script>
<script src="//use.typekit.net/sbk6prm.js"></script>
<script>try{Typekit.load();}catch(e){}</script>
<script>(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,'script','//www.google-analytics.com/analytics.js','ga');ga('create','UA-60954107-1','auto');ga('send','pageview');</script>
</head>

<body class="page page-id-23 page-child parent-pageid-19 page-template-default"><noscript><meta HTTP-EQUIV="refresh" content="0;url='http://vascepahcp.com/vascepa-other-biomarkers?ModPagespeed=noscript'" /><style><!--table,div,span,font,p{display:none} --></style><div style="display:block">Please click <a href="http://vascepahcp.com/vascepa-other-biomarkers?ModPagespeed=noscript">here</a> if you are not redirected within a few seconds.</div></noscript>
<div id="wrapper">
<div class="header">
<div class="logo">
<a href="http://vascepahcp.com">
<img src="http://vascepahcp.com/wp-content/themes/Vascepa/images/logo.png" height="200" width="980" alt="Vascepa" title="Go back to home" pagespeed_url_hash="1309676970">
</a>
</div>
<div class="right-side">
<nav class="top-nav"><div class="menu-top-menu-container"><ul id="menu-top-menu" class="menu"><li id="menu-item-436" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-436"><a href="#isi">Important Safety Information</a></li>
<li id="menu-item-43" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-43"><a target="_blank" href="http://www.vascepahcp.com/wp-content/uploads/2015/03/vascepa-pi-ppi-clean-P00120G-1-15.pdf">Full Prescribing Information</a></li>
<li id="menu-item-504" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-504"><a href="http://www.vascepa.com/">Patient Website</a></li>
<li id="menu-item-364" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-364"><a href="http://vascepahcp.com/wp-content/uploads/2015/05/VASCEPA-Formulary-Coverage.pdf">Formulary Coverage</a></li>
</ul></div></nav>
<nav class="mobile-nav"><div class="menu-mobile-top-menu-container"><ul id="menu-mobile-top-menu" class="menu"><li id="menu-item-438" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-438"><a href="http://pbwebd.com/vascepa/wp-content/uploads/2015/03/vascepa-pi-ppi-clean-P00120G-1-15.pdf">Full Prescribing Information</a></li>
<li id="menu-item-437" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-437"><a href="http://vascepa.com">Patient Site</a></li>
</ul></div></nav>
<div class="header-button desktop"><a href="http://vascepahcp.com/wp-content/uploads/50890_ANCHOR_Brochure.pdf" target="_blank"><img src="http://vascepahcp.com/wp-content/uploads/anchor-trial-button.png" pagespeed_url_hash="4038197889"></a></div>
<div class="tagline">For US Health Care Professionals Only</div>
<nav class="main-nav"><div class="menu-main-menu-container"><ul id="menu-main-menu" class="menu"><li id="menu-item-513" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-513"><a href="http://vascepahcp.com/managing-vhtg/">Managing VHTG</a><div class="mobile-arrow"></div>
<ul class="sub-menu">
<li id="menu-item-514" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-514"><a href="http://vascepahcp.com/importance-of-ldl-c">Impact of LDL-C</a><div class="mobile-arrow"></div></li>
<li id="menu-item-515" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-515"><a href="http://vascepahcp.com/epa-and-dha">EPA and DHA</a><div class="mobile-arrow"></div></li>
<li id="menu-item-516" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-516"><a href="http://vascepahcp.com/moa-of-epa">MOA of EPA</a><div class="mobile-arrow"></div></li>
<li id="menu-item-517" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-517"><a href="http://vascepahcp.com/epa-purity">EPA purity</a><div class="mobile-arrow"></div></li>
<li id="menu-item-518" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-518"><a href="http://vascepahcp.com/vascepa-vs-dietary-supplements">Dietary supplements</a><div class="mobile-arrow"></div></li>
</ul>
</li>
<li id="menu-item-519" class="menu-item menu-item-type-post_type menu-item-object-page current-page-ancestor current-menu-ancestor current-menu-parent current-page-parent current_page_parent current_page_ancestor menu-item-has-children menu-item-519"><a href="http://vascepahcp.com/efficacy">Efficacy</a><div class="mobile-arrow"></div>
<ul class="sub-menu">
<li id="menu-item-520" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-520"><a href="http://vascepahcp.com/vascepa-efficacy">TG and LDL-C</a><div class="mobile-arrow"></div></li>
<li id="menu-item-521" class="menu-item menu-item-type-post_type menu-item-object-page current-menu-item page_item page-item-23 current_page_item menu-item-521"><a href="http://vascepahcp.com/vascepa-other-biomarkers">Other atherogenic biomarkers</a><div class="mobile-arrow"></div></li>
<li id="menu-item-522" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-522"><a href="http://vascepahcp.com/vascepa-marine-design-and-baseline">MARINE trial details</a><div class="mobile-arrow"></div></li>
</ul>
</li>
<li id="menu-item-523" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-523"><a href="http://vascepahcp.com/vascepa-safety-tolerability">Safety</a><div class="mobile-arrow"></div></li>
<li id="menu-item-524" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-524"><a href="http://vascepahcp.com/vascepa-dosing-administration">Dosing</a><div class="mobile-arrow"></div></li>
<li id="menu-item-525" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-525"><a href="http://vascepahcp.com/contact-us">Contact Us</a><div class="mobile-arrow"></div>
<ul class="sub-menu">
<li id="menu-item-526" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-526"><a href="http://vascepahcp.com/vascepa-contact-us/">Request form</a><div class="mobile-arrow"></div></li>
<li id="menu-item-527" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-527"><a href="http://vascepahcp.com/vascepa-contact-amarin">Contact Amarin</a><div class="mobile-arrow"></div></li>
</ul>
</li>
</ul></div></nav>
</div>
<div class="header-button mobile"><a href="http://vascepahcp.com/wp-content/uploads/50890_ANCHOR_Brochure" target="_blank"><img src="http://vascepahcp.com/wp-content/uploads/anchor-trial-button.png" pagespeed_url_hash="4038197889"></a></div>
<div class="clear"></div>
<div id="toggle"><div class="menu-text">MENU</div> <img src="http://vascepahcp.com/wp-content/themes/Vascepa/images/toggle.png" pagespeed_url_hash="230623979"></div>
</div>
<div id="content" class="content-wrap">	
<div id="page-content">
<div class="breadcrumbs">
<ul>
<a href="http://vascepahcp.com/vascepa-efficacy">
<li>
<p>TG and LDL-C</p>
</li>
</a>
<a href="http://vascepahcp.com/vascepa-other-biomarkers">
<li class="current-page">
<p>Other atherogenic biomarkers</p>
</li>
</a>
<a href="http://vascepahcp.com/vascepa-marine-design-and-baseline">
<li>
<p>MARINE trial details</p>
</li>
</a>
</ul>
</div>
<div class="center-col">
<div class="page-text">
<h1>VASCEPA Significantly Reduced Other Atherogenic Lipid Biomarkers As Compared To Placebo<sup>1,2</sup></h1>
<p>The effects of VASCEPA 4 g/d were assessed in a randomized, placebo-controlled, double-blind, parallel-group study evaluating patients with fasting TG levels ≥500 mg/dL and ≤2000 mg/dL (with or without statin therapy).</p>
<p>The primary study endpoint was the placebo-adjusted median percent change in TG levels from baseline to study end (Week 12).</p>
<h5>Median percentage change from baseline vs placebo</h5>
<div class="enlarge-wrap">
<img class="enlarge alignnone wp-image-293 size-full" title="chart showing VASCEPA reduced other atherogenic biomarkers" src="http://www.vascepahcp.com/wp-content/uploads/2015/03/VLDL-C-Non-HDL-C-Apo-B-Chart.png" alt="chart showing VASCEPA reduced other atherogenic biomarkers" width="1136" height="306" pagespeed_url_hash="1292155602"/>
<img class="click-img aligncenter wp-image-382 size-full" src="http://www.vascepahcp.com/wp-content/uploads/2015/03/VLDL-C-Non-HDL-C-Apo-B-Chart-thumb.png" alt="VLDL-C,-Non-HDL-C,-Apo-B-Chart-thumb" width="640" height="179" pagespeed_url_hash="802121267"/>
</div>
<p><span style="font-size: 12px;">VLDL-C: VASCEPA (n=76), 20% median decrease from baseline; placebo (n=75), 14% increase from baseline; non-HDL-C: VASCEPA (n=76), 8% median decrease from baseline; placebo (n=75), 8% increase from baseline; Apo B: VASCEPA (n=75), 4% median decrease from baseline; placebo (n=73), 4% increase from baseline.</span></p>
<h3>VASCEPA significantly reduced total LDL particle number by 16% compared to placebo.<sup>3</sup></h3>
<p><span style="font-size: 12px;">Apo B, apolipoprotein B; LDL, low-density lipoprotein; non-HDL-C, non-high-density lipoprotein</span></p>
</div>
<a id="isi"></a>
<div class="disclaimer"><h6><strong>Indication and Limitations of Use</strong></h6>
<p>VASCEPA (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia.</p>
<ul>
<li>The effect of VASCEPA on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined.</li>
<li>The effect of VASCEPA on cardiovascular mortality and morbidity in patients with severe hypertriglyceridemia has not been determined.</li>
</ul>
<h6><strong>Important Safety Information for VASCEPA</strong></h6>
<ul>
<li>VASCEPA is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to VASCEPA or any of its components.</li>
<li>Use with caution in patients with known hypersensitivity to fish and/or shellfish.</li>
<li>The most common reported adverse reaction (incidence &gt;2% and greater than placebo) was arthralgia.</li>
<li>Patients receiving treatment with VASCEPA and other drugs affecting coagulation (e.g., anti-platelet agents) should be monitored periodically.</li>
<li>In patients with hepatic impairment, monitor ALT and AST levels periodically during therapy.</li>
<li>Patients should be advised to swallow VASCEPA capsules whole; not to break open, crush, dissolve, or chew VASCEPA.</li>
<li>Adverse events may be reported by calling 1-855-VASCEPA or the FDA at 1‑800‑FDA‑1088.</li>
</ul>
<p><strong>See full <a href="http://vascepahcp.com/wp-content/uploads/2015/03/vascepa-pi-ppi-clean-P00120G-1-15.pdf" target="_blank">Prescribing Information</a> for more information on VASCEPA.</strong></p>
</div>                                    <div class="references">
<strong>References:</strong> <strong>1.</strong> VASCEPA [package insert]. Bedminster, NJ: Amarin Pharma Inc.; 2015. <strong>2.</strong> Bays HE, Ballantyne CM, Kastelein JJ, Isaacsohn JL, Braeckman RA, Soni PN. Eicosapentaenoic acid ethyl ester (AMR101) therpay in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial). <em>Am J Cardiol.</em> 2011;108(5):682-690. <strong>3.</strong> Bays HE, Braeckman RA, Ballantyne CM, et al. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study). <em>J Clin Lipidol.</em> 2012; 6(6):565-572.                    </div>
</div>
<div class="page-sidebar">
<div class="sidebar">
<a href="http://www.vascepahcp.com/vascepa-contact-us/">	<div class="simple-image">
<img width="84" height="76" src="http://vascepahcp.com/wp-content/uploads/2015/03/callout-1.png" class="attachment-full" alt="callout-1" pagespeed_url_hash="4270985161"/>		<div class="simple-text">
<h3>Ask a representative to contact you</h3><p>Our VASCEPA sales representatives are happy to meet with you to discuss VASCEPA and deliver samples.</p>
</div>
<hr class="home-mobile">
</div>
</a></div><div class="disclaimer"><h6><strong>Indication and Limitations of Use</strong></h6>
<p>VASCEPA (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia.</p>
<ul>
<li>The effect of VASCEPA on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined.</li>
<li>The effect of VASCEPA on cardiovascular mortality and morbidity in patients with severe hypertriglyceridemia has not been determined.</li>
</ul>
<h6><strong>Important Safety Information for VASCEPA</strong></h6>
<ul>
<li>VASCEPA is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to VASCEPA or any of its components.</li>
<li>Use with caution in patients with known hypersensitivity to fish and/or shellfish.</li>
<li>The most common reported adverse reaction (incidence &gt;2% and greater than placebo) was arthralgia.</li>
<li>Patients receiving treatment with VASCEPA and other drugs affecting coagulation (e.g., anti-platelet agents) should be monitored periodically.</li>
<li>In patients with hepatic impairment, monitor ALT and AST levels periodically during therapy.</li>
<li>Patients should be advised to swallow VASCEPA capsules whole; not to break open, crush, dissolve, or chew VASCEPA.</li>
<li>Adverse events may be reported by calling 1-855-VASCEPA or the FDA at 1‑800‑FDA‑1088.</li>
</ul>
<p><strong>See full <a href="http://vascepahcp.com/wp-content/uploads/2015/03/vascepa-pi-ppi-clean-P00120G-1-15.pdf" target="_blank">Prescribing Information</a> for more information on VASCEPA.</strong></p>
</div>			</div>
</div>

</div>
</div>
<footer>
<div class="footer-bar">
<nav class="bar-nav"><div class="menu-bar-nav-container"><ul id="menu-bar-nav" class="menu"><li id="menu-item-529" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-529"><a href="http://vascepahcp.com/managing-vhtg/">Treating very high TG</a>
<ul class="sub-menu">
<li id="menu-item-530" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-530"><a href="http://vascepahcp.com/importance-of-ldl-c">LDL-C is important</a></li>
<li id="menu-item-531" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-531"><a href="http://vascepahcp.com/epa-and-dha">Different omega-3s</a></li>
<li id="menu-item-532" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-532"><a href="http://vascepahcp.com/moa-of-epa">How EPA works</a></li>
<li id="menu-item-533" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-533"><a href="http://vascepahcp.com/epa-purity">VASCEPA is ≥96% EPA</a></li>
<li id="menu-item-534" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-534"><a href="http://vascepahcp.com/vascepa-vs-dietary-supplements">Omega-3 fish oil supplements</a></li>
</ul>
</li>
<li id="menu-item-535" class="menu-item menu-item-type-post_type menu-item-object-page current-page-ancestor current-menu-ancestor current-menu-parent current-page-parent current_page_parent current_page_ancestor menu-item-has-children menu-item-535"><a href="http://vascepahcp.com/efficacy">How VASCEPA works</a>
<ul class="sub-menu">
<li id="menu-item-536" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-536"><a href="http://vascepahcp.com/vascepa-efficacy">Lower TGs—without compromising LDL-C</a></li>
<li id="menu-item-537" class="menu-item menu-item-type-post_type menu-item-object-page current-menu-item page_item page-item-23 current_page_item menu-item-537"><a href="http://vascepahcp.com/vascepa-other-biomarkers">Effects on VLDL-C, non-HDL-C, and Apo B</a></li>
<li id="menu-item-538" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-538"><a href="http://vascepahcp.com/vascepa-marine-design-and-baseline">The MARINE study</a></li>
</ul>
</li>
<li id="menu-item-539" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-539"><a href="http://vascepahcp.com/vascepa-safety-tolerability">How VASCEPA is tolerated</a>
<ul class="sub-menu">
<li id="menu-item-540" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-540"><a href="http://vascepahcp.com/vascepa-safety-tolerability">Effect on GI</a></li>
<li id="menu-item-541" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-541"><a href="http://vascepahcp.com/vascepa-safety-tolerability">Other tolerability</a></li>
</ul>
</li>
<li id="menu-item-542" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-542"><a href="http://vascepahcp.com/vascepa-dosing-administration">How to take VASCEPA</a>
<ul class="sub-menu">
<li id="menu-item-543" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-543"><a href="http://vascepahcp.com/vascepa-dosing-administration">Prescribing VASCEPA</a></li>
<li id="menu-item-544" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-544"><a href="http://vascepahcp.com/vascepa-dosing-administration">VASCEPA PK</a></li>
</ul>
</li>
<li id="menu-item-545" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-545"><a href="http://vascepahcp.com/contact-us">Contact us</a>
<ul class="sub-menu">
<li id="menu-item-548" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-548"><a href="http://vascepahcp.com/vascepa-contact-us/">See a sales rep</a></li>
<li id="menu-item-547" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-547"><a href="http://vascepahcp.com/vascepa-contact-us/">Request free samples</a></li>
<li id="menu-item-549" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-549"><a href="http://vascepahcp.com/vascepa-contact-us/">Saving money with VASCEPA</a></li>
<li id="menu-item-546" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-546"><a href="http://vascepahcp.com/vascepa-contact-amarin">Contact Amarin</a></li>
</ul>
</li>
</ul></div></nav>
<nav class="mobile-bar-nav"><div class="menu-mobile-bar-nav-container"><ul id="menu-mobile-bar-nav" class="menu"><li id="menu-item-550" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-550"><a href="http://vascepahcp.com/managing-vhtg/">Treating very high TG</a>
<ul class="sub-menu">
<li id="menu-item-551" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-551"><a href="http://vascepahcp.com/importance-of-ldl-c">LDL-C is important</a></li>
<li id="menu-item-552" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-552"><a href="http://vascepahcp.com/epa-and-dha">Different omega-3s</a></li>
<li id="menu-item-553" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-553"><a href="http://vascepahcp.com/moa-of-epa">How EPA works</a></li>
<li id="menu-item-554" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-554"><a href="http://vascepahcp.com/epa-purity">VASCEPA is ≥96% EPA</a></li>
<li id="menu-item-555" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-555"><a href="http://vascepahcp.com/vascepa-vs-dietary-supplements">Omega-3 fish oil supplements</a></li>
</ul>
</li>
<li id="menu-item-556" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-556"><a href="http://vascepahcp.com/vascepa-safety-tolerability">How VASCEPA is tolerated</a>
<ul class="sub-menu">
<li id="menu-item-557" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-557"><a href="http://vascepahcp.com/vascepa-safety-tolerability">Effect on GI</a></li>
<li id="menu-item-558" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-558"><a href="http://vascepahcp.com/vascepa-safety-tolerability">Other tolerability</a></li>
<li id="menu-item-559" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-559"><a href="http://vascepahcp.com/vascepa-dosing-administration">How to take VASCEPA</a></li>
<li id="menu-item-560" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-560"><a href="http://vascepahcp.com/vascepa-dosing-administration">Prescribing VASCEPA</a></li>
<li id="menu-item-561" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-561"><a href="http://vascepahcp.com/vascepa-dosing-administration">VASCEPA PK</a></li>
</ul>
</li>
<li id="menu-item-562" class="menu-item menu-item-type-post_type menu-item-object-page current-page-ancestor current-menu-ancestor current-menu-parent current-page-parent current_page_parent current_page_ancestor menu-item-has-children menu-item-562"><a href="http://vascepahcp.com/efficacy">How VASCEPA works</a>
<ul class="sub-menu">
<li id="menu-item-563" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-563"><a href="http://vascepahcp.com/vascepa-efficacy">Lower TGs—without compromising LDL-C</a></li>
<li id="menu-item-564" class="menu-item menu-item-type-post_type menu-item-object-page current-menu-item page_item page-item-23 current_page_item menu-item-564"><a href="http://vascepahcp.com/vascepa-other-biomarkers">Effects on VLDL-C, non-HDL-C, and Apo B</a></li>
<li id="menu-item-565" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-565"><a href="http://vascepahcp.com/vascepa-marine-design-and-baseline">The MARINE study</a></li>
</ul>
</li>
<li id="menu-item-566" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-566"><a href="http://vascepahcp.com/contact-us">Contact Us</a>
<ul class="sub-menu">
<li id="menu-item-567" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-567"><a href="http://vascepahcp.com/vascepa-contact-us/">See a sales rep</a></li>
<li id="menu-item-568" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-568"><a href="http://vascepahcp.com/vascepa-contact-us/">Request free samples</a></li>
<li id="menu-item-569" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-569"><a href="http://vascepahcp.com/vascepa-contact-us/">Saving money with VASCEPA</a></li>
<li id="menu-item-570" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-570"><a href="http://vascepahcp.com/vascepa-contact-amarin">Contact Amarin</a></li>
</ul>
</li>
</ul></div></nav>
</div>
<div class="footer-bottom">
<div class="footer-left">
<nav class="bottom-nav"><div class="menu-footer-menu-container"><ul id="menu-footer-menu" class="menu"><li id="menu-item-432" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-432"><a href="http://investor.amarincorp.com/publications.cfm">Publications</a></li>
<li id="menu-item-433" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-433"><a target="_blank" href="http://www.vascepahcp.com/wp-content/uploads/2015/03/vascepa-pi-ppi-clean-P00120G-1-15.pdf">Full Prescribing Information</a></li>
<li id="menu-item-64" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-64"><a href="http://vascepahcp.com/site-map/">Site Map</a></li>
<li id="menu-item-434" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-434"><a target="_blank" href="http://www.vascepahcp.com/wp-content/uploads/2015/03/Amarin_Privacy_Policy.pdf">Privacy Policy</a></li>
<li id="menu-item-435" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-435"><a target="_blank" href="http://amarincorp.com">Amarin</a></li>
</ul></div></nav>
<div class="footer-text">			<div class="textwidget"><p>&copy; 2015 Amarin Pharma Inc. All rights reserved.<br/>
VASCEPA<sup>&reg;</sup> is a registered trademark of the Amarin group of companies.<br/>
150270.3 &nbsp;&nbsp;&nbsp; 08/15</p>
</div>
</div><div class="footer-text">			<div class="textwidget"><p>This website, Vascepa.com, Vascepasavings.com, LowerMyTrigs.com, and the corporation's website, amarincorp.com, are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, Vascepa<sup>&reg;</sup> (icosapent ethyl) capsules. The Amarin group of companies is not responsible for false or misleading materials contained on other non-Amarin-controlled websites or other social media sites.</p>
</div>
</div>			</div>
<div class="footer-right">
<div class="footer-logo">
<div class="simple-image">
<img width="193" height="41" src="http://vascepahcp.com/wp-content/uploads/2015/03/Amarin-logo.png" class="attachment-full" alt="Amarin logo" pagespeed_url_hash="4155282919"/>		<div class="simple-text">
<p>Amarin Pharma Inc.<br/>
Bedminster, NJ 07921 USA<br/>
Tel: 1-855-VASCEPA (827-2372)</p>
</div>
<hr class="home-mobile">
</div>
</div>			</div>
</div>
<div class="mobile-isi">
<img id="isi-tab" src="http://vascepahcp.com/wp-content/themes/Vascepa/images/mobile-isi.png" pagespeed_url_hash="2598111075">
<div class="isi-content">
<div class="disclaimer"><h6><strong>Indication and Limitations of Use</strong></h6>
<p>VASCEPA (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia.</p>
<ul>
<li>The effect of VASCEPA on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined.</li>
<li>The effect of VASCEPA on cardiovascular mortality and morbidity in patients with severe hypertriglyceridemia has not been determined.</li>
</ul>
<h6><strong>Important Safety Information for VASCEPA</strong></h6>
<ul>
<li>VASCEPA is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to VASCEPA or any of its components.</li>
<li>Use with caution in patients with known hypersensitivity to fish and/or shellfish.</li>
<li>The most common reported adverse reaction (incidence &gt;2% and greater than placebo) was arthralgia.</li>
<li>Patients receiving treatment with VASCEPA and other drugs affecting coagulation (e.g., anti-platelet agents) should be monitored periodically.</li>
<li>In patients with hepatic impairment, monitor ALT and AST levels periodically during therapy.</li>
<li>Patients should be advised to swallow VASCEPA capsules whole; not to break open, crush, dissolve, or chew VASCEPA.</li>
<li>Adverse events may be reported by calling 1-855-VASCEPA or the FDA at 1‑800‑FDA‑1088.</li>
</ul>
<p><strong>See full <a href="http://vascepahcp.com/wp-content/uploads/2015/03/vascepa-pi-ppi-clean-P00120G-1-15.pdf" target="_blank">Prescribing Information</a> for more information on VASCEPA.</strong></p>
</div>            </div>
</div>
</footer>
<div id="intro" class="popup">
<div class="intro-wrap">
<div class="popup-shadow">
<div id="close-intro"><img src="http://vascepahcp.com/wp-content/themes/Vascepa/images/close-intro.png" pagespeed_url_hash="1234463290"></div>
<div class="intro-header"><img src="http://vascepahcp.com/wp-content/themes/Vascepa/images/web-introducing-banner.png" pagespeed_url_hash="2856992741"></div>
<div class="intro-red">ADDITIONAL DATA:</div>
<div class="intro-blue">STATIN PATIENTS WITH</div>
<div class="intro-red">TG levels 200 to 499 mg/dL</div>
<div class="intro-tagline">Read about the ANCHOR Study*</div>
<div class="intro-learn">
<a href="http://vascepahcp.com/wp-content/uploads/50890_ANCHOR_Brochure.pdf" target="_blank"><img src="http://vascepahcp.com/wp-content/themes/Vascepa/images/web-learn-more-button-red.png" pagespeed_url_hash="630476427"></a>
</div>
<div class="intro-subtitle">*Results from a randomized clinical trial published<br>
in <em>The American Journal of Cardiology.</em></div>
</div>
</div>
</div>

<script type='text/javascript' src='http://vascepahcp.com/wp-content/plugins/contact-form-7/includes/js/jquery.form.min.js?ver=3.51.0-2014.06.20'></script>
<script type='text/javascript'>//<![CDATA[
var _wpcf7={"loaderUrl":"http:\/\/vascepahcp.com\/wp-content\/plugins\/contact-form-7\/images\/ajax-loader.gif","sending":"Sending ..."};
//]]></script>
<script type='text/javascript' src='http://vascepahcp.com/wp-content/plugins/contact-form-7/includes/js/scripts.js?ver=4.2.2'></script>

<script pagespeed_no_defer="">//<![CDATA[
(function(){var e=encodeURIComponent,f=window,h=document,m="width",n="documentElement",p="height",q="length",r="prototype",s="body",t="&",u="&ci=",w="&n=",x="&rd=",y=",",z="?",A="Content-Type",B="Microsoft.XMLHTTP",C="Msxml2.XMLHTTP",D="POST",E="application/x-www-form-urlencoded",F="img",G="input",H="load",I="oh=",J="on",K="pagespeed_url_hash",L="url=",M=function(a,c,d){if(a.addEventListener)a.addEventListener(c,d,!1);else if(a.attachEvent)a.attachEvent(J+c,d);else{var b=a[J+c];a[J+c]=function(){d.call(this);b&&b.call(this)}}};f.pagespeed=f.pagespeed||{};var N=f.pagespeed,O=function(a,c,d,b,g){this.d=a;this.f=c;this.g=d;this.a=g;this.c={height:f.innerHeight||h[n].clientHeight||h[s].clientHeight,width:f.innerWidth||h[n].clientWidth||h[s].clientWidth};this.e=b;this.b={}};O[r].j=function(a){a=a.getBoundingClientRect();return{top:a.top+(void 0!==f.pageYOffset?f.pageYOffset:(h[n]||h[s].parentNode||h[s]).scrollTop),left:a.left+(void 0!==f.pageXOffset?f.pageXOffset:(h[n]||h[s].parentNode||h[s]).scrollLeft)}};O[r].i=function(a){if(0>=a.offsetWidth&&0>=a.offsetHeight)return!1;a=this.j(a);var c=a.top.toString()+y+a.left.toString();if(this.b.hasOwnProperty(c))return!1;this.b[c]=!0;return a.top<=this.c[p]&&a.left<=this.c[m]};O[r].l=function(){for(var a=[F,G],c=[],d={},b=0;b<a[q];++b)for(var g=h.getElementsByTagName(a[b]),k=0;k<g[q];++k){var v=g[k].getAttribute(K);v&&g[k].getBoundingClientRect&&this.i(g[k])&&!(v in d)&&(c.push(v),d[v]=!0)}b=!1;a=I+this.g;this.a&&(a+=w+this.a);if(0!=c[q]){a+=u+e(c[0]);for(b=1;b<c[q];++b){d=y+e(c[b]);if(131072<a[q]+d[q])break;a+=d}b=!0}this.e&&(d=x+e(JSON.stringify(this.h())),131072>=a[q]+d[q]&&(a+=d),b=!0);N.criticalImagesBeaconData=a;if(b){var c=this.d,b=this.f,l;if(f.XMLHttpRequest)l=new XMLHttpRequest;else if(f.ActiveXObject)try{l=new ActiveXObject(C)}catch(P){try{l=new ActiveXObject(B)}catch(Q){}}l&&(l.open(D,c+(-1==c.indexOf(z)?z:t)+L+e(b)),l.setRequestHeader(A,E),l.send(a))}};O[r].h=function(){for(var a={},c=h.getElementsByTagName(F),d=0;d<c[q];++d){var b=c[d],g=b.getAttribute(K);if("undefined"==typeof b.naturalWidth||"undefined"==typeof b.naturalHeight||"undefined"==typeof g)break;if("undefined"==typeof a[b.src]&&0<b[m]&&0<b[p]&&0<b.naturalWidth&&0<b.naturalHeight||"undefined"!=typeof a[b.src]&&b[m]>=a[b.src].n&&b[p]>=a[b.src].m)a[g]={renderedWidth:b[m],renderedHeight:b[p],originalWidth:b.naturalWidth,originalHeight:b.naturalHeight}}return a};N.k=function(a,c,d,b,g){var k=new O(a,c,d,b,g);M(f,H,function(){f.setTimeout(function(){k.l()},0)})};N.criticalImagesBeaconInit=N.k;})();pagespeed.criticalImagesBeaconInit('/mod_pagespeed_beacon','http://vascepahcp.com/vascepa-other-biomarkers','9fxyNymV5S',false,'jdn0srkYPEQ');
//]]></script></body>
</html>